ArticleAtherosclerosis plus2025
Inclisiran for fast-track lipid-lowering treatment early after an acute coronary syndrome: a pilot study.
Alessandro Lupi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it